MedPath

Comparing two ways to predict who will survive in the ICU: One uses a scoring system called APACHE IV score, while the other estimates Serum Hepcidin levels through a blood test

Phase 4
Conditions
Health Condition 1: 4- Measurement and Monitoring
Registration Number
CTRI/2024/05/067373
Lead Sponsor
Government Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age more than 18 years,

Below 65 years,

Patient in ICU stay more than 48 hours

Exclusion Criteria

1. Refusal to consent from patient’s relative

2. ICU stay less than 2 days (shift to ward or discharge within 2 days)

3. Burns

4. Head injury

5. Patients receiving chemotherapy/ having malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of Acute Physiology and Chronic Health Evaluation IV score and serum hepcidin levels as predictor of mortality in patients admitted to intensive care unitTimepoint: APACHE IV score will be calculated within 24 hours of admission in ICU. <br/ ><br>Serum hepcidin level measured after 48 hours of admission in ICU.
Secondary Outcome Measures
NameTimeMethod
Correlation of APACHE IV score with development of sepsis and length of stay in ICUTimepoint: APACHE IV score will be calculated within 24 hours of admission in ICU.;Correlation of serum hepcidin levels with development of sepsis and length of stay in ICUTimepoint: Serum hepcidin level will be measured after 48 hours of admission in ICU.;Correlation of SOFA score to predict the development of sepsisTimepoint: SOFA score calculated after 48 hours of admission and will be done every alternate days at a given designated time
© Copyright 2025. All Rights Reserved by MedPath